What are Edwards Lifesciences's profit margins?

Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.

Where do Edwards Lifesciences's ratios come from?

Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Edwards Lifesciences EW Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	77.9%-1.6pp	78%-1.4pp	78.2%-1.6pp	78.9%-0.7pp	79.5%-0.1pp
Operating margin	21.4%-4.4pp	20.8%-4.5pp	24.2%-2.3pp	25.8%-1.6pp	25.8%-0.1pp
Net margin	17.4%-58.3pp	17.7%-59.1pp	23.2%-54.9pp	73%+44.7pp	75.7%+48.1pp
EBITDA margin	23.9%-4.6pp	23.4%-4.8pp	26.9%-2.5pp	28.5%-1.8pp	28.6%-0.2pp
Free cash flow margin	17.3%—	22%—	——	——	——
Returns
Return on equity	10.7%-37.8pp	10.6%-39.6pp	13.9%-37.5pp	46.1%+24.8pp	48.5%+26.9pp
Return on assets	8.3%-28.4pp	8%-29.2pp	10.4%-26.8pp	35.2%+19.7pp	36.7%+21.4pp
Return on invested capital	13.7%-4.1pp	13.3%-4.7pp	16.4%-4.1pp	17.6%-3.0pp	17.8%-1.3pp
Efficiency
Asset turnover	0.5×0.0×	0.5×0.0×	0.4×0.0×	0.5×-0.1×	0.5×-0.1×
Inventory turnover	1.2×+0.3×	1.2×+0.1×	1.1×+0.1×	1.1×0.0×	1×0.0×
Liquidity
Current ratio	4.4×0.0×	3.7×-0.5×	4×+0.5×	4.7×+1.0×	4.5×+0.7×
Quick ratio	3.6×0.0×	3.1×-0.4×	3.3×+0.4×	3.9×+1.0×	3.7×+1.0×
Cash ratio	1.7×-0.5×	1.6×-0.4×	1.7×-0.2×	2.3×+1.0×	2.3×+1.2×
Leverage
Debt-to-equity	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Net debt / EBITDA	-1.2×+0.4×	-1.6×0.0×	-1.3×+0.6×	-1.6×-1.0×	-1.6×-1.2×
Per Share
Book value per share	$17.78+3.2%	$17.65+5.8%	$17.42+9.2%	$17.94+45.7%	$17.23+46.2%
Valuation
Market capitalization	$46.17B+8.7%	$49.47B+13.3%	$45.66B+14.9%	$44.49B-20.1%	$42.46B-26.2%
Enterprise value	$44.42B+11.0%	$47.24B+14.4%	$43.66B+18.7%	$41.91B-23.4%	$40.01B-29.8%
Price / earnings	42.1×+32.0×	46.1×+35.6×	33.4×+23.8×	10.7×-27.1×	10.2×-30.5×
Price / sales	7.3×-0.4×	8.2×+0.1×	7.8×+0.3×	7.8×-2.9×	7.7×-3.5×
Price / book	4.5×+0.3×	4.8×+0.4×	4.5×+0.3×	4.2×-3.3×	4.2×-3.9×
EV / EBITDA	29.5×+4.1×	33.2×+6.3×	27.6×+4.1×	25.9×-8.8×	25.4×-13.3×
EV / sales	7×-0.2×	7.8×+0.2×	7.4×+0.5×	7.4×-3.1×	7.2×-3.9×
Free cash flow yield	2.4%—	2.7%—	——	——	——
Earnings yield	2.4%-7.5pp	2.2%-7.4pp	3%-7.5pp	9.3%+6.7pp	9.8%+7.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Edwards Lifesciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Edwards Lifesciences's profit margins?: Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.
Where do Edwards Lifesciences's ratios come from?: Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.